Treatment of Kasabach–Merritt syndrome: a stepwise regimen of prednisolone, dipyridamole, and interferon
- 3 September 2003
- journal article
- research article
- Published by Wiley in International Journal of Dermatology
- Vol. 42 (9) , 741-748
- https://doi.org/10.1046/j.1365-4362.2003.01796.x
Abstract
Background Kasabach–Merritt syndrome (KMS) is a rare, aggressive, vascular tumor with thrombocytopenia and consumptive coagulopathy. A standard treatment regimen for KMS has not been established. We...Keywords
This publication has 24 references indexed in Scilit:
- Effective therapy of a vascular tumor of infancy with vincristineJournal of Pediatric Surgery, 2001
- Early surgical intervention in a patient with Kasabach-Merritt phenomenonThe Journal of Pediatrics, 2001
- Kasabach–merritt syndrome: pathogenesis and managementBritish Journal of Haematology, 2001
- Residual lesions after Kasabach-Merritt phenomenon in 41 patients☆, ☆☆Journal of the American Academy of Dermatology, 2000
- Infants with Kasabach-Merritt syndrome do not have “true” hemangiomasThe Journal of Pediatrics, 1997
- Kaposiform haemangioendothelioma associated with Kasabach‐Merritt syndromeHistopathology, 1996
- Kasabach-Merritt coagulopathy complicating Klippel-Trenaunay-Weber syndrome in pregnancyObstetrics & Gynecology, 1995
- Kaposiform Hemangioendothelioma of Infancy and ChildhoodThe American Journal of Surgical Pathology, 1993
- Interferon Alfa-2a Therapy for Life-Threatening Hemangiomas of InfancyNew England Journal of Medicine, 1992
- CAPILLARY HEMANGIOMA WITH EXTENSIVE PURPURAAmerican Journal of Diseases of Children, 1940